NYSE · Healthcare · Medical Instruments & Supplies · USA
Resmed Inc is a large cap company (market value between $10 billion and $200 billion) in the Medical Instruments & Supplies industry.
Resmed designs and manufactures digital health and cloud-connected medical devices for sleep, breathing, and related health disorders. The company provides CPAP systems, ventilation devices, diagnostic products, masks and accessories, dental devices, and cloud-based software for care management and patient monitoring. Resmed sells its products globally through subsidiaries and distributors, serving healthcare providers and patients in home and hospital settings.
From its FY2026 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Resmed Inc stock.
Fairly valued: intrinsic value $241.77 per share, market price $239.77, margin of safety 0.8% (as of 2026-10-19).
Discounting its cash flows at 9.1% (average of 3 methods) values the shares at $241.77; the price of $239.77 is 1% below that value, and 76% of that value comes from beyond year five.
Leak Score: 74/100 on 12 of 12 signals (Clear Leak).
17 more funds hold it; the full list is part of the paid plan.
All 50 Medical Instruments & Supplies stocks
RMD is fairly valued (as of the 2026-10-19 close). Discounting its cash flows at 9.1% (average of 3 methods) values the shares at $241.77; the price of $239.77 is 1% below that value, and 76% of that value comes from beyond year five.
$241.77 per share (as of the 2026-10-19 close), against a market price of $239.77. That is a margin of safety of 0.8%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
74 out of 100, which we rate "Clear Leak", on 12 of 12 value investing signals.